Role for Immune Therapy in Advanced Breast Cancer [News in Brief]

Data suggest that pembrolizumab can control growth of trastuzumab-resistant HER2-positive tumors.

from Cancer via ola Kala on Inoreader http://ift.tt/2BXHdg8
via IFTTT